CPT® Code 50593

The procedure described by CPT® Code 50593 involves the ablation of one or more renal tumors through a technique known as cryotherapy, which is performed unilaterally and via a percutaneous approach. In this context, "ablation" refers to the process of destroying tumor tissue, and "cryotherapy" specifically utilizes extreme cold to achieve this destruction. The procedure is guided by imaging techniques such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI), which are separately reportable. These imaging modalities are essential for accurately identifying the tumor(s) and ensuring precise placement of the cryotherapy probes. During the procedure, multiple probes may be necessary to ensure that the entire tumor is effectively destroyed while also providing adequate margins of healthy tissue. The entry points for these probes are carefully determined, and small incisions are made to facilitate their insertion. The probes are then guided into the center of the tumor(s) using the aforementioned imaging techniques, with particular attention paid to avoiding surrounding organs and major blood vessels. Once the probes are correctly positioned, the cryoablation unit is activated, and the probes are filled with argon gas, which allows for rapid freezing of the tumor tissue at temperatures that can reach as low as -100 degrees centigrade. Following the freezing phase, a thawing cycle is initiated by replacing the argon gas with helium, which is crucial for the ablation process. Throughout the procedure, imaging guidance continues to be utilized to monitor the formation of the cryoablation sphere, commonly referred to as an "ice ball," and to assess the extent of tumor necrosis. Typically, complete destruction of the tumor requires two freeze/thaw cycles. Upon completion of the treatment, the probes are carefully withdrawn, the skin incisions are cleansed, and a dressing is applied to the site to promote healing.